Oakworth Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-4,491
| Closed | -$825K | – | 612 |
|
2021
Q2 | $825K | Hold |
4,491
| – | – | 0.08% | 75 |
|
2021
Q1 | $687K | Hold |
4,491
| – | – | 0.08% | 82 |
|
2020
Q4 | $702K | Hold |
4,491
| – | – | 0.09% | 72 |
|
2020
Q3 | $514K | Buy |
4,491
+200
| +5% | +$22.9K | 0.08% | 83 |
|
2020
Q2 | $482K | Buy |
4,291
+2,091
| +95% | +$235K | 0.09% | 83 |
|
2020
Q1 | $198K | Hold |
2,200
| – | – | 0.05% | 134 |
|
2019
Q4 | $239K | Hold |
2,200
| – | – | 0.04% | 143 |
|
2019
Q3 | $215K | Hold |
2,200
| – | – | 0.04% | 145 |
|
2019
Q2 | $288K | Hold |
2,200
| – | – | 0.05% | 133 |
|
2019
Q1 | $297K | Hold |
2,200
| – | – | 0.06% | 128 |
|
2018
Q4 | $214K | Hold |
2,200
| – | – | 0.05% | 147 |
|
2018
Q3 | $306K | Hold |
2,200
| – | – | 0.06% | 129 |
|
2018
Q2 | $273K | Hold |
2,200
| – | – | 0.06% | 136 |
|
2018
Q1 | $259K | Buy |
2,200
+200
| +10% | +$23.5K | 0.06% | 133 |
|
2017
Q4 | $220K | Hold |
2,000
| – | – | 0.05% | 150 |
|
2017
Q3 | $285K | Hold |
2,000
| – | – | 0.07% | 120 |
|
2017
Q2 | $243K | Hold |
2,000
| – | – | 0.07% | 135 |
|
2017
Q1 | $242K | Sell |
2,000
-48
| -2% | -$5.81K | 0.07% | 137 |
|
2016
Q4 | $251K | Hold |
2,048
| – | – | 0.08% | 129 |
|
2016
Q3 | $251K | Hold |
2,048
| – | – | 0.09% | 118 |
|
2016
Q2 | $309K | Hold |
2,048
| – | – | 0.12% | 101 |
|
2016
Q1 | $285K | Hold |
2,048
| – | – | 0.11% | 100 |
|
2015
Q4 | $391K | Hold |
2,048
| – | – | 0.16% | 78 |
|
2015
Q3 | $320K | Hold |
2,048
| – | – | 0.17% | 54 |
|
2015
Q2 | $404K | Hold |
2,048
| – | – | 0.19% | 52 |
|
2015
Q1 | $347K | Hold |
2,048
| – | – | 0.16% | 67 |
|
2014
Q4 | $379K | Buy |
2,048
+2,000
| +4,167% | +$370K | 0.2% | 61 |
|
2014
Q3 | $8K | Hold |
48
| – | – | ﹤0.01% | 302 |
|
2014
Q2 | $8K | Hold |
48
| – | – | ﹤0.01% | 303 |
|
2014
Q1 | $7K | Hold |
48
| – | – | ﹤0.01% | 309 |
|
2013
Q4 | $6K | Buy |
+48
| New | +$6K | ﹤0.01% | 303 |
|